Page last updated: 2024-10-28

hydroxychloroquine and Brain Thrombosis

hydroxychloroquine has been researched along with Brain Thrombosis in 2 studies

Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)
hydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.

Research Excerpts

ExcerptRelevanceReference
"Severe and potentially fatal deep cerebral thrombosis may complicate the initial clinical presentation of COVID-19."1.56Cerebral Venous Thrombosis Associated with COVID-19. ( Cavalcanti, DD; Dehkharghani, S; Jain, R; Lillemoe, K; Nelson, PK; Nossek, E; Radmanesh, A; Raz, E; Riina, HA; Shapiro, M; Torres, J; Yaghi, S, 2020)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Cavalcanti, DD1
Raz, E1
Shapiro, M1
Dehkharghani, S1
Yaghi, S1
Lillemoe, K1
Nossek, E1
Torres, J1
Jain, R1
Riina, HA1
Radmanesh, A1
Nelson, PK1
Hsu, YW1
Juan, CJ1
Lee, JT1
Lin, YK1
Lai, CH1
Yang, FC1

Other Studies

2 other studies available for hydroxychloroquine and Brain Thrombosis

ArticleYear
Cerebral Venous Thrombosis Associated with COVID-19.
    AJNR. American journal of neuroradiology, 2020, Volume: 41, Issue:8

    Topics: Adult; Azithromycin; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Fem

2020
Anti-N-Methyl-D-Aspartate-Receptor Encephalitis Complicated With Antiphospholipid Syndrome and Cerebral Venous Thrombosis.
    Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases, 2017, Volume: 23, Issue:5

    Topics: Anti-N-Methyl-D-Aspartate Receptor Encephalitis; Antiphospholipid Syndrome; Antirheumatic Agents; Br

2017